Clinical Trials Logo

Filter by:
NCT ID: NCT06255119 Completed - Opioid Use Disorder Clinical Trials

The Feasibility of VR for OUD

Start date: October 18, 2022
Phase: N/A
Study type: Interventional

This study aims to evaluate feasibility of a virtual reality software device and measure the effects of the intervention on OUD patient mood, tension and cravings, as well as the effect of treatment on patient retention to their inpatient detox protocol.

NCT ID: NCT06255093 Recruiting - Anxiety Clinical Trials

You & Me Healthy: Youth Empowered Self-Care Substudy (YES)

YES
Start date: February 13, 2024
Phase: N/A
Study type: Interventional

You & Me Healthy: Youth Empowered Self-Care, or YES, is a study that aims to link 150 youth ages 8-12 and families to free or low-cost community-based programs, resources, and clinical care options that promote mental wellness and help reduce anxiety. Community-based programs can include: - Afterschool programs - Local parks and recreation activities - Youth social programming

NCT ID: NCT06255054 Recruiting - Cannabis Use Clinical Trials

Novel Approaches to Assessing Cannabis Impaired Driving (NAACID)

NAACID
Start date: June 20, 2020
Phase:
Study type: Observational

Researchers at the University of Colorado Anschutz Medical Campus, Colorado School of Public Health, and Injury & Violence Prevention Center want to learn more about how people are affected by cannabis in different ways. We will use a driving simulator to compare the driving performance of adults who use cannabis daily, occasionally or have not recently used cannabis.

NCT ID: NCT06254950 Recruiting - Ulcerative Colitis Clinical Trials

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis

Start date: March 29, 2024
Phase: Phase 2
Study type: Interventional

The main aim of this study is to learn if TAK-279 reduces bowel inflammation and symptoms compared to placebo. Another aim is to compare any medical problems that participants have when they take TAK-279 or placebo and how well the participants tolerate any problems. The participants will take capsules of either TAK-279 or placebo for up to 3 months (12 weeks). Then all the participants will receive TAK-279 for the rest of the treatment part of the study (1 year or 52 weeks). During the study, participants will visit their study clinic several times.

NCT ID: NCT06254911 Recruiting - Clinical trials for Oropharynx Cancer, Stage I

Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma

Start date: October 27, 2023
Phase: Phase 2
Study type: Interventional

This phase II trial tests how well atezolizumab works in treating patients with human papillomavirus (HPV) related oropharyngeal squamous cell carcinoma that is able to be removed with surgery (resectable). Immunotherapy with atezolizumab, may include changes in the body's immune system and may interfere with the ability of tumor cells to grow and spread.

NCT ID: NCT06254898 Recruiting - Healthy Clinical Trials

Use of Incentives for Stressful Medical Procedures

Start date: June 2, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn about the use of incentives in pediatric patients requiring medical procedures. The main questions it aims to answer are: - Are incentives effective at reducing pediatric anxiety for medical procedures? - What is the best way to use incentives with pediatric populations requiring medical procedures? Participants will be provided support in preparation for their procedure and during the procedure by a child life specialist and might receive an incentive prize after their procedure. Participants distress levels during the procedure will be observed and they will be asked to rate their anxiety on a visual analog scale. Researchers will compare the anxiety of those who did or did not receive an incentive after their procedure to see if incentives reduced procedural anxiety.

NCT ID: NCT06254833 Recruiting - Clinical trials for Perfusion; Complications

Microdosing ICG for Serial Colonic Perfusion Study During Surgery

Start date: November 1, 2023
Phase: N/A
Study type: Interventional

using microdosing of ICG vs regular dosing of ICG for perfusion assessment during surgery

NCT ID: NCT06254807 Recruiting - HER2-positive Clinical Trials

CAR-monocytes for the Treatment of HER2 Overexpressing Solid Tumors

Start date: January 8, 2024
Phase: Phase 1
Study type: Interventional

This is a first-in-human open-label study to evaluate the safety and tolerability, and manufacturing feasibility of anti-HER2 CAR-monocytes (CT-0525) in participants with locally advanced (unresectable) or metastatic solid tumors overexpressing HER2 whose disease has progressed on standard approved therapies.

NCT ID: NCT06254794 Recruiting - Clinical trials for Achilles Tendon Rupture

Effect of BFR Rehab After Achilles Tendon Rupture

Start date: November 13, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if blood flow restriction therapy after Achilles tendon rupture reconstruction decreases post-operative calf atrophy, improves reported outcomes, and ultimately decreases return to play time.

NCT ID: NCT06254768 Recruiting - Pediatric Obesity Clinical Trials

Use of Continuous Glucose Monitors in Children and Adolescents With Obesity

CGM
Start date: January 17, 2023
Phase: N/A
Study type: Interventional

To study if continuous glucose monitors are feasible for use in children and adolescents with obesity.